カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の細胞・遺伝子治療生体分析検査サービス市場2023-2030：検査種類別、開発段階別、製品種類別、疾患別、地域別

【英語タイトル】Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Test Type, By Stage Of Development, By Product Type, By Indication, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN027）・商品コード：GRV23JUN027
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月30日
・ページ数：175
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,324,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の細胞・遺伝子治療生体分析検査サービス市場規模が、予測期間中（2023年～2030年）に年平均7.3％増加し、2030年までに8,287億ドルへ達すると見込まれています。本調査書では、細胞・遺伝子治療生体分析検査サービスの世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、検査種類別（生物学的利用能・生物学的同等性研究、薬物動態学、薬力学、その他検査）分析、製品種類別（遺伝子療法、遺伝子改変細胞療法、細胞療法）分析、開発段階別（非臨床、臨床）分析、疾患別（腫瘍、感染症、神経疾患、希少疾患、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、BioAgilytix Labs、KCAS Bioanalytical Services、IQVIA, Inc.、Laboratory Corporation of America Holdings、Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)、Prolytix、Pharmaron、Charles River Laboratoriesなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界細胞・遺伝子治療生体分析検査サービスの市場規模：検査種類別
- 生物学的利用能・生物学的同等性研究検査の市場規模
- 薬物動態学検査の市場規模
- 薬力学検査の市場規模
- その他検査の市場規模
・世界細胞・遺伝子治療生体分析検査サービスの市場規模：製品種類別
- 遺伝子療法の市場規模
- 遺伝子改変細胞療法の市場規模
- 細胞療法の市場規模
・世界細胞・遺伝子治療生体分析検査サービスの市場規模：開発段階別
- 非臨床における市場規模
- 臨床における市場規模
・世界細胞・遺伝子治療生体分析検査サービスの市場規模：疾患別
- 腫瘍における市場規模
- 感染症における市場規模
- 神経疾患における市場規模
- 希少疾患における市場規模
- その他疾患における市場規模
・世界細胞・遺伝子治療生体分析検査サービスの市場規模：地域別
- 北米の細胞・遺伝子治療生体分析検査サービス市場規模
- ヨーロッパの細胞・遺伝子治療生体分析検査サービス市場規模
- アジア太平洋の細胞・遺伝子治療生体分析検査サービス市場規模
- 中南米の細胞・遺伝子治療生体分析検査サービス市場規模
- 中東・アフリカの細胞・遺伝子治療生体分析検査サービス市場規模
・競争状況

細胞・遺伝子治療生体分析検査サービス市場

Grand View Research, Inc.の最新レポートによると、世界の細胞・遺伝子治療生体分析検査サービス市場規模は、2023年から2030年まで年平均成長率7.3%で拡大し、2030年までに8,287億米ドルに達すると予測されています。細胞・遺伝子治療に関連する研究開発活動の増加、細胞・遺伝子治療研究のための公的機関による資金提供、希少疾患の治療における遺伝子・細胞治療の高い可能性が、細胞・遺伝子治療生体分析検査サービス産業の成長を促進する主な要因です。

細胞療法と遺伝子療法は、がん、自己免疫疾患、希少疾患の治療に広く使用されています。これらの治療法は患者の臨床状態に著しい改善を示しており、そのため多くの細胞・遺伝子治療薬候補が承認に向けてパイプラインに並んでいます。例えば、米国細胞・遺伝子治療学会（American Society of Cell and Gene Therapy）によると、2023年1月現在、2,053以上の遺伝子治療薬と827の非遺伝子組換え細胞治療薬がパイプラインにあります。パイプラインにある細胞治療薬や遺伝子治療薬の候補の多さが、同市場におけるバイオ分析検査サービスの需要を促進しています。

公的機関や民間企業は、細胞・遺伝子治療ベースの研究に積極的に投資しています。例えば、2023年4月、California Institute for Regenerative Medicineは幹細胞・遺伝子治療研究に8,900万米ドルを投資しました。この資金は、持続性角膜上皮欠損の治療法の開発に使われました。今後、同様の資金援助が行われることで、予測期間中のバイオ分析検査サービスの需要が高まることが予想されます。

COVID-19パンデミックは、細胞・遺伝子治療生体分析検査サービス産業の成長に打撃を与えました。パンデミックの間、細胞・遺伝子治療ベースの試験の大半が延期されました。しかし、COVID-19後の時代には、シナリオが変わりつつあります。試験の大半が再開されました。このことは、COVID-19後の期間における市場の成長を支えるものと予想されます。

細胞・遺伝子治療生体分析検査サービス市場レポートハイライト

– 検査の種類別に見ると、薬物動態学セグメントは予測期間中CAGR 7.5%で成長する見込みです。この種の試験は医薬品開発時に必要であり、また、体内での医薬品の安全性と有効性を特定するのに役立ちます。そのため、同分野の需要を押し上げています。

– 製品タイプ別では、細胞療法が2022年に42.3%の最大売上シェアを占めました。細胞療法は、自己免疫疾患や癌などの治療において大きな可能性を秘めています。これは、細胞治療の臨床研究の成長を助け、細胞治療のバイオ分析サービスの需要を後押ししています。

– 製品タイプ別の開発段階に基づくと、非臨床セグメントは2022年に66.1%のシェアを占めました。非臨床目的のバイオ分析試験は、IND承認取得に不可欠です。治療法を臨床段階に移行させるための研究者の高い需要が、このセグメントの市場成長を支えています。

– 適応症に基づくと、2022年にはがん領域が48.9%と最大の売上シェアを占めました。がん細胞を効果的に治療する遺伝子・細胞治療の高い可能性が、この分野の市場成長の主な理由です。

– アジア太平洋地域は、予測期間中に7.6%という最も高いCAGRを記録すると予測されています。公的機関による細胞・遺伝子治療ベースの研究への資金援助と、同地域におけるバイオ分析サービスのアウトソーシングに関連する低コストは、同セグメント市場の成長を支えています。

❖ レポートの目次 ❖

Table of content

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Test Type
1.1.3. Product Type
1.1.4. Stage of Development by Product Type
1.1.5. Indication
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cell & Gene Therapy Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Significant Number Of Cell & Gene Therapy Drug Candidates Under Clinical Trials
3.2.1.2. High Public And Private Investments Across Research And Development Of Novel Cell & Gene Products To Augment Market Growth
3.2.1.3. High Focus Of Biopharmaceutical Companies To Reduce Operational Costs Promoting The Demand For Outsourcing
3.2.2. Market Restraint Analysis
3.2.2.1. Availability Of Alternative Treatment Options At Lower Cost
3.2.2.2. Quality Issues Associated With Outsourcing
3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.3.4. Total Number of Approved Cell & Gene Therapies (2022)
3.3.4.1. Gene Therapies
3.3.4.2. Cell Therapies
3.3.5. Funding/Investment Analysis:
3.3.5.1. Investment/Funding in Cell Therapies
3.3.5.2. Investment/Funding in Gene Therapies
3.3.6. Pipeline Analysis:
3.3.6.1. Gene Therapies
3.3.6.2. Cell Therapies
3.3.7. Volume of Cell & Gene Clinical Trials
3.3.7.1. By Region
3.3.7.2. By Sponsor
3.3.7.3. By Study Design
3.3.8. Merger & Acquisition Deals in Cell & Gene Therapy (2018 to 2022)
Chapter 4. Cell & Gene Therapy Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis
4.1. Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type: Segment Dashboard
4.2. Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type: Movement Analysis
4.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 – 2030
4.3.1. Bioavailability & Bioequivalence Studies
4.3.1.1. Bioavailability & Bioequivalence Studies Cell & Gene Therapy Bioanalytical Testing Services Market, 2018 to 2030 (USD Million)
4.3.2. Pharmacokinetics
4.3.2.1. Pharmacokinetics Cell & Gene Therapy Bioanalytical Testing Services Market, 2018 to 2030 (USD Million)
4.3.3. Pharmacodynamics
4.3.3.1. Pharmacodynamics Cell & Gene Therapy Bioanalytical Testing Services Market, 2018 to 2030 (USD Million)
4.3.4. Other test type
4.3.4.1. Other test type Cell & Gene Therapy Bioanalytical Testing Services Market, 2018 to 2030 (USD Million)
Chapter 5. Cell & Gene Therapy Bioanalytical Testing Services Market: Product Type Estimates & Trend Analysis
5.1. Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type: Segment Dashboard
5.2. Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type: Movement Analysis
5.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Product Type, 2018 – 2030
5.3.1. Gene Therapy
5.3.1.1. Gene Therapy Market, 2018 to 2030 (USD Million)
5.3.1.2. Ex-vivo
5.3.1.2.1. Ex-vivo Market, 2018 to 2030 (USD Million)
5.3.1.3. In-vivo
5.3.1.3.1. In-vivo Market, 2018 to 2030 (USD Million)
5.3.2. Gene-Modified Cell Therapy
5.3.2.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
5.3.2.2. CAR T-cell therapies
5.3.2.2.1. CAR T-Cell Therapies Market, 2018 to 2030 (USD Million)
5.3.2.3. CAR-NK cell therapy
5.3.2.3.1. CAR-NK Cell Therapy Market, 2018 to 2030 (USD Million)
5.3.2.4. TCR-T cell therapy
5.3.2.4.1. TCR-T Cell Therapy Market, 2018 to 2030 (USD Million)
5.3.2.5. Others
5.3.2.5.1. Others Market, 2018 to 2030 (USD Million)
5.3.3. Cell Therapy
5.3.3.1. Cell Therapy Market, 2018 to 2030 (USD Million)
Chapter 6. Cell & Gene Therapy Bioanalytical Testing Services Market: Stage of Development by Product Type Estimates & Trend Analysis
6.1. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of development by product type by Product Type: Segment Dashboard
6.2. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage of development by product type by Product Type: Movement Analysis
6.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, Stage of Development by Product Type, 2018 – 2030
6.3.1. Non-Clinical
6.3.1.1. Non-Clinical Market, 2018 to 2030 (USD Million)
6.3.1.2. Gene Therapy
6.3.1.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
6.3.1.3. Gene-Modified Cell Therapy
6.3.1.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
6.3.1.4. Cell Therapy
6.3.1.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
6.3.2. Clinical
6.3.2.1. Clinical Market, 2018 to 2030 (USD Million)
6.3.2.2. Gene Therapy
6.3.2.2.1. Gene Therapy Market, 2018 to 2030 (USD Million)
6.3.2.3. Gene-Modified Cell Therapy
6.3.2.3.1. Gene-Modified Cell Therapy Market, 2018 to 2030 (USD Million)
6.3.2.4. Cell Therapy
6.3.2.4.1. Cell Therapy Market, 2018 to 2030 (USD Million)
Chapter 7. Cell & Gene Therapy Bioanalytical Testing Services Market: Indication Estimates & Trend Analysis
7.1. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Segment Dashboard
7.2. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication: Movement Analysis
7.3. Cell & Gene Therapy Bioanalytical Testing Services Market Estimates & Forecasts, By Indication, 2018 – 2030
7.3.1. Oncology
7.3.1.1. Oncology Cell & Gene Therapy Bioanalytical Testing Services Market 2018 to 2030 (USD Million)
7.3.2. Infectious Diseases
7.3.2.1. Infectious Diseases Cell & Gene Therapy Bioanalytical Testing Services Market 2018 to 2030 (USD Million)
7.3.3. Neurological Disorders
7.3.3.1. Neurological Disorders Cell & Gene Therapy Bioanalytical Testing Services Market 2018 to 2030 (USD Million)
7.3.4. Rare Diseases
7.3.4.1. Rare Diseases Cell & Gene Therapy Bioanalytical Testing Services Market 2018 to 2030 (USD Million)
7.3.5. Others
7.3.5.1. Others Cell & Gene Therapy Bioanalytical Testing Services Market 2018 to 2030 (USD Million)
Chapter 8. Cell & Gene Therapy Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2022 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. Market Estimates and Forecast, 2018 – 2030 (Revenue, USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. U.S. Market Estimates and Forecasts, 2018 – 2030
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Canada Market Estimates and Forecasts, 2018 – 2030
8.5. Europe
8.5.1. UK
8.5.1.1. Key Country Dynamics
8.5.1.2. Competitive Scenario
8.5.1.3. Regulatory Framework
8.5.1.4. UK Market Estimates and Forecasts, 2018 – 2030
8.5.2. Germany
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Germany Market Estimates and Forecasts, 2018 – 2030
8.5.3. France
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. France Market Estimates and Forecasts, 2018 – 2030
8.5.4. Italy
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Italy Market Estimates and Forecasts, 2018 – 2030
8.5.5. Spain
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Spain Market Estimates and Forecasts, 2018 – 2030
8.5.6. Denmark
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Denmark Market Estimates and Forecasts, 2018 – 2030
8.5.7. Sweden
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Sweden Market Estimates and Forecasts, 2018 – 2030
8.5.8. Norway
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Norway Market Estimates and Forecasts, 2018 – 2030
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. Japan Market Estimates and Forecasts, 2018 – 2030
8.6.2. India
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. India Market Estimates and Forecasts, 2018 – 2030
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. China Market Estimates and Forecasts, 2018 – 2030
8.6.4. South Korea
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. South Korea Market Estimates and Forecasts, 2018 – 2030
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Australia Market Estimates and Forecasts, 2018 – 2030
8.6.6. Thailand
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Thailand Market Estimates and Forecasts, 2018 – 2030
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Brazil Market Estimates and Forecasts, 2018 – 2030
8.7.2. Mexico
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Mexico Market Estimates and Forecasts, 2018 – 2030
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Argentina Market Estimates and Forecasts, 2018 – 2030
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key Country Dynamics
8.8.1.2. Competitive Scenario
8.8.1.3. Regulatory Framework
8.8.1.4. South Africa Market Estimates and Forecasts, 2018 – 2030
8.8.2. Saudi Arabia
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 – 2030
8.8.3. UAE
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. UAE Market Estimates and Forecasts, 2018 – 2030
8.8.4. Kuwait
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. Kuwait Market Estimates and Forecasts, 2018 – 2030
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Innovators
9.1.2. Market Leaders
9.1.3. Emerging Players
9.1.4. Company Market Share Analysis, 2022
9.2. Company Profiles
9.2.1. BioAgilytix Labs
9.2.1.1. Company Overview
9.2.1.2. Financial Performance
9.2.1.3. Service Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. KCAS Bioanalytical Services
9.2.2.1. Company Overview
9.2.2.2. Financial Performance
9.2.2.3. Service Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. IQVIA, Inc.
9.2.3.1. Company Overview
9.2.3.2. Financial Performance
9.2.3.3. Service Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Laboratory Corporation of America Holdings
9.2.4.1. Company Overview
9.2.4.2. Financial Performance
9.2.4.3. Service Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
9.2.5.1. Company Overview
9.2.5.2. Financial Performance
9.2.5.3. Service Benchmarking
9.2.5.4. Strategic Initiatives
9.2.6. Prolytix
9.2.6.1. Company Overview
9.2.6.2. Financial Performance
9.2.6.3. Service Benchmarking
9.2.6.4. Strategic Initiatives
9.2.7. Pharmaron
9.2.7.1. Company Overview
9.2.7.2. Financial Performance
9.2.7.3. Service Benchmarking
9.2.7.4. Strategic Initiatives
9.2.8. Charles River Laboratories
9.2.8.1. Company Overview
9.2.8.2. Financial Performance
9.2.8.3. Service Benchmarking
9.2.8.4. Strategic Initiatives
9.2.9. Syneos Health
9.2.9.1. Company Overview
9.2.9.2. Financial Performance
9.2.9.3. Service Benchmarking
9.2.9.4. Strategic Initiatives
9.2.10. SGS SA
9.2.10.1. Company Overview
9.2.10.2. Financial Performance
9.2.10.3. Service Benchmarking
9.2.10.4. Strategic Initiatives
9.2.11. Intertek Group Plc
9.2.11.1. Company Overview
9.2.11.2. Financial Performance
9.2.11.3. Service Benchmarking
9.2.11.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 4 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 5 North America Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 6 North America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 7 North America Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 8 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 9 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 10 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 11 U.S. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 12 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 13 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 14 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 15 Canada Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 16 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 17 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 18 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 19 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 20 Europe Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 21 U.K. Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 22 U.K. Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 23 U.K. Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 24 U.K. Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 25 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 26 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 27 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 28 Germany Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 29 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 30 France Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 31 France Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 32 France Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 33 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 34 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 35 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 36 Italy Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 37 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 38 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 39 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 40 Spain Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 41 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 42 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 43 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 44 Denmark Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 45 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 46 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 47 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 48 Sweden Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 49 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 50 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 51 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 52 Norway Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 53 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 54 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 55 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 58 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 59 China Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 60 China Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 61 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 62 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 63 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 64 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 65 Japan Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 66 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 67 India Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 68 India Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 69 India Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 70 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 71 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 72 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 73 Australia Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 74 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 75 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 76 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 77 South Korea Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 78 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 79 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 80 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 81 Thailand Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 82 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 83 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 84 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 85 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 86 Latin America Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 87 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 88 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 89 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 90 Brazil Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 91 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 92 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 93 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 94 Mexico Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 95 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 96 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 97 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 98 Argentina Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 99 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 100 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 101 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 102 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 103 Middle East And Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 104 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 105 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 106 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 107 South Africa Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 112 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 113 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 114 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 115 UAE Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)
Table 116 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2018 - 2030 (USD Million)
Table 117 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2018 - 2030 (USD Million)
Table 118 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, Stage Of Development By Product Type, 2018 - 2030 (USD Million)
Table 119 Kuwait Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication, 2018 - 2030 (USD Million)

★調査レポート[世界の細胞・遺伝子治療生体分析検査サービス市場2023-2030：検査種類別、開発段階別、製品種類別、疾患別、地域別] (コード：GRV23JUN027)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の細胞・遺伝子治療生体分析検査サービス市場2023-2030：検査種類別、開発段階別、製品種類別、疾患別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の細胞＆遺伝子治療製造市場2023-2030：治療タイプ別、規模別（R&D）、モード別、ワークフロー別（ベクター生産、セルバンキング）、地域別
  • 世界のプラスミドDNA製造市場2024-2030：疾患別（癌、感染症）、グレード別（R&Dグレード、GMPグレード）、用途別、開発段階別、地域別
  • 世界の医薬品無菌性試験市場（2023-2030）：製品種類別（装置、サービス）、種類別（アウトソーシング、インハウス）、検査種類別、サンプル別、エンドユーザー別、地域別
  • 世界の細胞・遺伝子療法製造市場2023-2031：治療種類別（細胞療法、遺伝子療法）、製品種類別（消耗品、機器、ソフトウェア）
  • 世界のペット用DNA検査市場2023-2030：検査種類別（遺伝性疾患、ヘルス・ウェルネス）、動物種類別（犬、猫）、サンプル種類別（血液、唾液）、エンドユーザー別
  • 世界のラテラルフローアッセイ市場2023-2030：製品別（キット・試薬）、用途別（臨床検査）、技術別、検査種類別、エンドユーザー別、地域別
  • 世界の細胞＆組織分析市場2023-2030：技術別（生体試料技術、細胞分離技術、細胞・組織特性評分析）、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆